Treatment-induced changes in tumor cells included bypassing KRAS inhibition, metabolic reprogramming, and EMT, while changes in the TME consisted of increased coagulation, angiogenesis, and immune suppression [165]. This evidence concerns the gene KRAS and neoplasm.